Drug Type Small molecule drug |
Synonyms Timocartin + [2] |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H40N8O7 |
InChIKeyCOIXXKVZEXZCLU-YXWQFLTLSA-N |
CAS Registry85466-18-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fractures, Bone | Phase 3 | CH | - | |
Fractures, Bone | Phase 3 | BE | - | |
Fractures, Bone | Phase 3 | - | - | |
Fractures, Bone | Phase 3 | DE | - | - |
Fractures, Bone | Phase 3 | - | - | |
Fractures, Bone | Phase 3 | - | - | |
Neoplasms | Phase 3 | CH | - | |
Neoplasms | Phase 3 | BE | - | |
Neoplasms | Phase 3 | DE | - | - |